1996
DOI: 10.1016/s0924-977x(96)00032-6
|View full text |Cite
|
Sign up to set email alerts
|

Piracetam and fipexide prevent PTZ-kindling-provoked amnesia in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
5
0

Year Published

2004
2004
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(5 citation statements)
references
References 39 publications
0
5
0
Order By: Relevance
“…Kindling is the neuroplasticity phenomenon suggested to be useful in the investigation of memory process 21 . Deficits in active and inhibitory avoidance responses have been found in PTZ‐kindled rats 22 . Many epidemiological studies have indicated that chronic use of non‐steroidal anti‐inflammatory drugs (NSAIDs) reduces the risk of developing Alzheimer's disease 23 .…”
Section: Discussionmentioning
confidence: 99%
“…Kindling is the neuroplasticity phenomenon suggested to be useful in the investigation of memory process 21 . Deficits in active and inhibitory avoidance responses have been found in PTZ‐kindled rats 22 . Many epidemiological studies have indicated that chronic use of non‐steroidal anti‐inflammatory drugs (NSAIDs) reduces the risk of developing Alzheimer's disease 23 .…”
Section: Discussionmentioning
confidence: 99%
“…It is well established that there is a suppression of γ‐amino butyric acid (GABAergic) transmission during epileptogenesis [8] which may result in the amplification of excitatory neurotransmission, culminating in emotional disorders such as anxiety and amnesia. These behavioral excitations such as increased locomotor activity, hyperalgesia and loss of memory have been established by numerous in vivo experiments [9,10]. The oxidative stress imposed during seizures is an outcome of free radicals produced from the abnormal structural alterations of cellular proteins, membrane lipids, DNA and RNA [11].…”
Section: Introductionmentioning
confidence: 99%
“…Fipexide (Vigilor®, 1‐[2‐(4‐chlorophenoxy)acetyl]‐4‐(3,4‐methylenedioxybenzyl)piperazine, Fig. 1) is a nootropic compound (smart drug) that acts as a mild stimulant, affecting dopamine levels in the brain, and is said to improve short‐term memory, learning and cognition 1–6. It has been withdrawn from the market due to adverse side effects, including liver toxicity7, 8 and severe fever 9.…”
mentioning
confidence: 99%